Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg | Getty Images Johnson & Johnson on Wednesday said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots. The FDA approved the pill, Icotyde, to treat…
Dividend-paying companies are rapidly closing the earnings growth gap with technology stocks and contributing more earnings momentum to the S&P 500. After a significant increase over the past year on this key earnings metric, the trend suggests that dividend stocks may present an even stronger case to investors seeking income and safety in a volatile…
The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the…
A woman carries a baby as she reacts after evacuating from Russian troop-occupied Kupiansk town in a bus convoy, amid Russia’s attack on Ukraine, on the outskirts of Kharkiv, Ukraine May 30, 2022. Picture taken May 30, 2022. Ivan Alvarado | Reuters Four years of war between Russia and Ukraine are beginning to take their…
The Supreme Court in Washington, Jan. 27, 2026. Al Drago | Bloomberg | Getty Images The Supreme Court may decide the fate of President Donald Trump’s tariff agenda as soon as Friday — and the ruling has implications for consumers’ wallets, according to economists. If the high court were to rule that certain tariffs are…
You sometimes have to leave the world of business to understand business. Right now, many of the biggest players in the hyper-competitive battle for AI dominance — including Microsoft, Google, Meta, Amazon, OpenAI, and Anthropic — are forcing us to question everything we know about how to value a stock. It’s turning us upside down….
CNBC’s Jim Cramer on Friday outlined what to watch in Wall Street’s week ahead, from key labor data to big earnings reports from McDonald’s, Robinhood and others. “There’s a lot going on next week, but the most important thing, believe it or not, is the Labor Department’s nonfarm payroll report on Wednesday,” Cramer said. “If…
Jim Cramer and Jeff Marks, the Club’s director of portfolio analysis, on Thursday delivered updates on all 34 Club holdings during the January Monthly Meeting. Here are the highlights from the first meeting of 2026, starting with our four turnaround stories: 4 turnaround plays Nike: The apparel and sneaker retailer has shown real signs of…
We’re heading into a holiday-shortened trading week. Don’t let that fool you, though. There’s enough on the calendar to fill a full week. Earnings season is ramping up. The Fed’s preferred inflation gauge is due out (albeit a little stale). And we’re having our first Monthly Meeting of the year. 1. Earnings outside the portfolio:…
We get so caught up in the buzz and the sizzle that we forget about the steak, especially in this era of GLP-1s, which have revolutionized the treatment of diabetes and obesity and are being studied for so many more diseases and conditions. That’s my chief takeaway from meeting with 15 different CEOs, a dozen…
